Market Cap (In SEK)
82.96 Million
Revenue (In SEK)
36.82 Million
Net Income (In SEK)
-15.4 Million
Avg. Volume
28.26 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.4-6.24
- PE
- -
- EPS
- -
- Beta Value
- 1.455
- ISIN
- SE0015244884
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Lars Minor
- Employee Count
- -
- Website
- https://www.newburypharma.com
- Ipo Date
- 2022-02-04
- Details
- Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
More Stocks
-
688305
-
VANTITechnicolor SA
VANTI
-
002720Kukje Pharma Co., Ltd.
002720
-
4512
-
JEMA
-
JINDALSTELJindal Steel & Power Limited
JINDALSTEL
-
ANRGFAnaergia Inc.
ANRGF
-
121600